Cart
sales@molnova.com
c-FMS-IN-8
CAS No. 885704-21-2
c-FMS-IN-8( —— )
Catalog No. M16411 CAS No. 885704-21-2
c-FMS-IN-8 is a potent, selective c-FMS kinase inhibitor with IC50 of 0.8 nM, shows activity in collagen-induced model of arthritis in mice.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 170 | Get Quote |
|
| 10MG | 260 | Get Quote |
|
| 25MG | 440 | Get Quote |
|
| 50MG | 617 | Get Quote |
|
| 100MG | 872 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Namec-FMS-IN-8
-
NoteResearch use only, not for human use.
-
Brief Descriptionc-FMS-IN-8 is a potent, selective c-FMS kinase inhibitor with IC50 of 0.8 nM, shows activity in collagen-induced model of arthritis in mice.
-
Descriptionc-FMS-IN-8 is a potent, selective c-FMS kinase inhibitor with IC50 of 0.8 nM, shows activity in collagen-induced model of arthritis in mice.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayTyrosine Kinase
-
TargetCSF1R
-
RecptorCSF1R
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number885704-21-2
-
Formula Weight406.5239
-
Molecular FormulaC23H30N6O
-
Purity>98% (HPLC)
-
SolubilityDMSO
-
SMILESCC1CCN(CC1)C2=C(C=CC(=C2)N3CCN(CC3)C)NC(=O)C4=CC(=CN4)C#N
-
Chemical Name1H-Pyrrole-2-carboxamide, 4-cyano-N-[4-(4-methyl-1-piperazinyl)-2-(4-methyl-1-piperidinyl)phenyl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Illig CR, et al. Bioorg Med Chem Lett. 2008 Mar 1;18(5):1642-8.
2. Meegalla SK, et al. Bioorg Med Chem Lett. 2008 Jun 15;18(12):3632-7.
molnova catalog
related products
-
GW2580
A potent, selective c-Fms (CSF1R) inhibitor that completely inhibits human cFMS kinase in vitro at 60 nM.
-
ARRY-382
ARRY-382 is a highly selective oral inhibitor of CSF-1R with an IC50 of 9 nM.
-
Emactuzumab
Emactuzumab(RG 7155) is a monoclonal antibody against colony-stimulating factor-1 receptor targeting tumor-associated macrophages (TAMs) Emactuzumab has antitumor activity and inhibits activation of colony-stimulating factor 1 receptor (CSF1R) Emactuzumab has a high affinity for CSF-1R with a Ki value of 0.2 nM.
